Cyntegrity is hosting the RQA 2026 conference in London

Cyntegrity enables predictable, inspection-ready clinical trials with AI-augmented Risk-Based Quality Management (RBQM) that goes beyond automation. Our technology supports human decision-making, not replaces it — preserving historical oversight records for full traceability over time, ensuring teams understand not only what changed, but why. Our MyRBQM® Portal provides portfolio-wide oversight—from protocol complexity analysis to patient-level signal detection—while our MyRBQM® Academy builds shared understanding and practical capability across study teams, CRO partners, and QA groups. We support sponsors, CROs, and regulators in operationalizing ICH E6(R3), E8(R1) and Q9(R1) consistently and at scale, ensuring that quality oversight remains fit-for-purpose, defendable, and future-proof. Powered by a diverse, international team, we help organizations evolve from reactive checks to predictive, insight-driven, human-in-control oversight that strengthens compliance, decision traceability, and resource focus across studies and portfolios.